CLSI C34A2

CLSI C34A2 describes sweat stimulation, collection, and the quantitative analysis of sweat chloride and sodium with an emphasis on avoiding evaporation and contamination.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.